Pharmafile Logo
Pharmafocus logo
Advanced Search
Roche image

Roche lung cancer drug sees first approval

July 4, 2014
Sales and Marketing ALK+, Cancer, NSCLC, Pfizer, Roche, Xalkori, alectinib, alk, zykadia

Roche has seen the first approval for its new lung cancer drug alectinib in Japan as it looks to compete …

News
FDA image

Spectrum wins FDA approval for rare cancer drug

July 4, 2014
Research and Development, Sales and Marketing Beleodaq, Cancer, FDA, Spectrum, non-Hodgkin lymphoma

In an expedited review the FDA has approved a new cancer drug from Spectrum Pharmaceuticals to treat a rare cancer …

News
st jude image

FDA clears St. Jude Medical

July 4, 2014
Manufacturing and Production, Sales and Marketing CardioMEMS, FDA, california, st jude medical

US medical device manufacturer St. Jude Medical has been given a clean bill of health by the Food and Drug …

News
NHS image

Unison warns of ‘dangerous’ £1 billion NHS tender

July 4, 2014
Sales and Marketing CCG, England, NHS, commissioning, unison

A row is bubbling over the provision of health services in Staffordshire after a trade union accused four NHS clinical …

News
ann-tove_kongsnes_

Pharmalink elects three to board

July 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann-Tove Kongsnes, Hilde Furberg, Olav Hellebø, Pharmalink, ab

Swedish speciality pharma firm Pharmalink AB has appointed Ann-Tove Kongsnes, Hilde Furberg and Olav Hellebø to its board of directors. …

Appointment

Majority of consumed Viagra fake say researchers

July 3, 2014
Manufacturing and Production, Sales and Marketing BMJ, ED, Pfizer, Sildenafil, counterfeit, erectile dysfunction, viagra

At least two-thirds of Pfizer’s erectile dysfunction drug Viagra used in the Netherlands may be illegal, researchers are warning. In …

News
novartis image

Novartis faces data fraud charges in Japan

July 3, 2014
Medical Communications, Sales and Marketing Diovan, Japan, Novartis, data, fraud, heart, valsartan

Novartis is facing criminal charges in Japan over the alleged falsifying of data for its once big-selling heart drug Diovan. …

News

France ‘to approve’ Avastin use

July 3, 2014
Sales and Marketing AMD, France, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

The French government is planning to allow Roche’s cancer drug Avastin to be prescribed off-label to treat wet age-related macular …

News
Genentech image

Genentech to buy Seragon

July 3, 2014
Sales and Marketing Genentech, Roche, breast cancer, oncology, serds

Roche subsidiary Genentech is to pay around $1.7 billion for biotech firm Seragon Pharmaceuticals to secure its portfolio of potential …

News
annalisa_prosensa

Prosensa makes two key appointments



July 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prosensa, Willem W. van Weperen. Annalisa Jenkins

Dutch biopharma firm Prosensa has appointed Willem W. van Weperen as chief commercial officer and Dr Annalisa Jenkins to its …

Appointment

World facing medical ‘dark ages’ over antibiotic resistance

July 2, 2014
Medical Communications, Research and Development, Sales and Marketing Antibiotics, BRIC, Cameron, MINT, UK, o'neill, oneill, resistance

The UK Government has pledged to become a world leader in tackling antibiotic resistance in the face of a medical …

News
Amgen image

FDA breakthrough for Amgen

July 2, 2014
Research and Development, Sales and Marketing Amgen, BiTE antibody blinatumomab, FDA, all, leukaemia

Amgen has taken a major step down the road to getting its investigational cancer drug blinatumomab onto the market after …

News
J&J image

J&J completes $4 billion OCD sale

July 2, 2014
Sales and Marketing J&J, JJ, Johnson and Johnson, Ortho-Clinical Diagnostics, carlyle, ocd

Johnson & Johnson has sold its Ortho-Clinical Diagnostics (OCD) business to private equity investor The Carlyle Group for ‘approximately $4 …

News

Fishawack buys Brighton comms agency

July 2, 2014
Medical Communications Brighton, Facilitate, comms, fishawack

Medical communications firm Fishawack has acquired the UK, Brighton-based agency Facilitate as part of its
 ongoing purchasing strategy. Facilitate will …

News
Merck image

PD-1 cancer race heats up as Merck takes lead

July 2, 2014
Research and Development, Sales and Marketing ASCO, Cancer, Merck, melanoma, mk3475, oncology, pembrolizumab

Merck’s oncology drug pembrolizumab has taken a big step towards becoming Europe’s first PD-1 cancer treatment as the EMA accepts …

News
james_smith_reuters_pfizer

Reuters chief executive joins Pfizer board

July 2, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, james smith, reuters

Pfizer has appointed the chief executive of information and media giant Thomson Reuters to its board of directors. James Smith …

Appointment

Doctors who miss cancer to be named and shamed

July 1, 2014
Sales and Marketing Cancer, GPs, Hunt, NHS, UK, doctors, oncology

In a new government initiative doctors who consistently fail to diagnose signs of cancer could be publically named on an …

News

BASF and chemical giants building new MDI plant

July 1, 2014
Manufacturing and Production BASF, China, Huntsman, SINOPEC, Shanghai, Shanghai Chlor-Alkali, Shanghai Hua Yi, mdi

BASF, Huntsman, Shanghai Hua Yi, Shanghai Chlor-Alkali and SINOPEC are teaming up to construct a new MDI plant in China. …

News
tatjana_dragovic_astellas

Astellas names Americas head

July 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Tatjana Dragovic, americas

Astellas has appointed Tatjana Dragovic as its VP and regional compliance officer for the firm’s Americas region. In this role …

Appointment
NHS image

Government gets £74m rebate from pharma

June 30, 2014
Sales and Marketing ABPI, Hunt, NHS, PPRS, VBP, emms, pricing

The UK government has received a £74 million refund from the pharma industry after it was deemed to have spent …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026